iBio
(NASDAQ) IBIO
iBio Financials at a Glance
Market Cap
$71.85M
Revenue (TTM)
$300.00K
Net Income (TTM)
$24.74M
EPS (TTM)
$-1.01
P/E Ratio
-2.07
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$2.20
Volume
675,189.802
Open
$2.15
Price
$2.20
Volume
675,189.802
Open
$2.15
Previous Close
$2.18
Daily Range
$2.12 - $2.24
52-Week Range
$0.56 - $4.74
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$2.20
Volume
675,189.802
Open
$2.15
Previous Close
$2.18
Daily Range
$2.12 - $2.24
52-Week Range
$0.56 - $4.74
IBIO News
Why iBio Stock Soared Today
Why iBio Stock Soared Today
Is It Too Late to Buy iBio Stock?
IBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout iBio
Industry
Biotechnology
Sector
Health CareEmployees
20
CEO
Martin B. Brenner, PhD, DVM
Website
www.ibioinc.comHeadquarters
Bryan, TX 77807, US
IBIO Financials
Key Financial Metrics (TTM)
Gross Margin
-77%
Operating Margin
-77%
Net Income Margin
-82%
Return on Equity
-70%
Return on Capital
-39%
Return on Assets
-38%
Earnings Yield
-48.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$71.85M
Shares Outstanding
34.54M
Volume
675.19K
Short Interest
0.00%
Avg. Volume
1.72M
Financials (TTM)
Gross Profit
$400.00K
Operating Income
$18.60M
EBITDA
$17.04M
Operating Cash Flow
$15.30M
Capital Expenditure
$16.00K
Free Cash Flow
$15.32M
Cash & ST Invst.
$8.58M
Total Debt
$3.51M
iBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$241.00K
-220.5%
Gross Margin
0.00%
N/A
Market Cap
$71.85M
N/A
Market Cap/Employee
$4.49M
N/A
Employees
16
N/A
Net Income
$8.99M
-106.1%
EBITDA
$6.70M
-66.5%
Quarterly Fundamentals
Net Cash
$50.25M
+1564.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$1.93M
-37.5%
Short Term Debt
$518.00K
-42.7%
Return on Assets
-38.42%
N/A
Return on Invested Capital
-39.28%
N/A
Free Cash Flow
$5.76M
-48.8%
Operating Cash Flow
$5.24M
-35.5%